Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Epilepsy & Behavior : E&B|May 4, 2015
Cross-sensitivity of patient-perceived adverse cognitive effects with antiepileptic drug useBaibing Chen, Kamil Detyniecki, Lawrence J Hirsch, et al.Epilepsia|June 19, 2007
Effect of age and comedication on levetiracetam pharmacokinetics and tolerabilityLawrence J Hirsch, Hiba Arif, Richard Buchsbaum, et al.Seizure|June 17, 2015
Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: An extended follow-upAsif Javed, Brian Cohen, Kamil Detyniecki, et al.JMIR Mental Health|November 4, 2022
Development of the First Episode Digital Monitoring mHealth Intervention for People With Early Psychosis: Qualitative Interview Study With CliniciansAna Stefancic, R Tyler Rogers, Sarah Styke, et al.Journal of Child Neurology|May 23, 2019
Effectiveness of Levetiracetam Monotherapy in Pediatric Patients With EpilepsyRafal D Mazur, Qianyu Wang Ba, Kenneth Kato Bs, et al.Epilepsy Research|May 6, 2017
Prevalence and risk factors of seizure clusters in adult patients with epilepsyBaibing Chen, Hyunmi Choi, Lawrence J Hirsch, et al.ESC Heart Failure|December 30, 2020
Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trialKenji Matsumoto, Yi Xiao, Shunichi Homma, et al.Mitochondrion|November 14, 2017
Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trialPeter W Stacpoole, Jonathan Shuster, John L P Seamus Thompson, et al.ESC Heart Failure|September 21, 2021
Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trialKazato Ito, Siyuan Li, Shunichi Homma, et al.Therapeutic Advances in Rare Disease|March 6, 2024
A United States-based patient-reported adult polyglucosan body disease registry: initial resultsJacy Sparks, Francesco Michelassi, John L P Thompson, et al.Pageof 6